SS Innovations International, Inc.

SSII Healthcare Medical Devices

SS Innovations International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $42.5 million, up 105.7% from fiscal 2024. In the quarter to June 2026, revenue grew 39.4%, EPS fell 669.2%, free cash flow fell 16.6% and total debt rose 109.7%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

2.53 0.05 −1.94%
Market cap
$517.2M
P/E
0.0×
Fwd P/E
−63.0×
Dividend yield
—
F-score
5/9
Altman Z
17.50
Beneish M
−0.72
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Total current assets
48.80 27.42 21.43 6.72 0.41 0.16 0.03 0.04 0.46 0.25
Total non-current assets
25.43 14.97 10.09 1.96 0.02 0.15 0.10 0.10 0.05 0.04
Total Assets
74.23 42.39 31.52 8.68 0.43 0.32 0.13 0.15 0.51 0.29
Total current liabilities
26.24 21.33 8.47 11.14 0.29 1.19 1.20 0.37 0.41 0.65
Total non-current liabilities
9.77 7.60 3.32 — — — — — — —
Total liabilities
36.01 28.93 11.80 11.14 0.29 1.19 1.20 0.37 0.41 0.65
Common Equity (Total)
38.22 13.46 19.72 (2.46) 0.14 (0.87) (1.06) (0.22) 0.10 (0.36)
Shareholders Equity (Total)
38.22 13.46 19.72 (2.46) 0.14 (0.87) (1.06) (0.22) 0.10 (0.36)
Total Debt
11.44 7.99 6.53 3.24 — — — — — —

Show all line items

In millions of $ except per-share values · columns are period end dates